RecruitingNCT06021340
What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?
Sponsor
Chinese University of Hong Kong
Enrollment
50 participants
Start Date
Jul 4, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Various to-be-discard material from IVF treatment cycle will be collect and examined, aiming to identify potential reasons of successful outcome or cycle failure.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with ivf and infertility. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06021340
Related Trials
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
NCT0734082711 locations
A Large-scale, Prospective Cohort Study Was Conducted to Explore the Association Between Environmental Exposure and Behavioral Factors and Infertility (the Success Rate of Assisted Reproductive Technology)
NCT076413871 location
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
NCT054406171 location
Inherited Reproductive Disorders
NCT015004472 locations
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
NCT030116841 location